Not sure where to start? Try searching for your diagnosis above or visit the "Conditions" section.
Curated scientific studies about autoimmune diseases.
This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or a qualified healthcare provider before making any health decisions. Full Disclaimer
A new clinical tool developed from a four-hospital Chinese study can predict survival outcomes in patients with MDA5-positive dermatomyositi...
Read More — Multicenter Study Develops Prognostic Nomogram for MDA5-Positive Dermatomyositis with Lung Disease »A critical appraisal of a large cohort study finds that neurological complications in dermatitis herpetiformis are likely significantly unde...
Read More — Neurological Complications in Dermatitis Herpetiformis May Be Underestimated by Standard Registry Data »A landmark phase 3 trial has found that brepocitinib, an oral TYK2/JAK1 inhibitor, significantly improved a comprehensive measure of disease...
Read More — Brepocitinib Achieves First Positive Phase 3 Trial Result in Dermatomyositis: The VALOR Study »A new review clarifies how the type of antibody driving cicatricial pemphigoid and related subepidermal blistering diseases influences both...
Read More — Antibody Class and Target Shape Disease Phenotype and Treatment in Cicatricial Pemphigoid and Related Conditions »A 2026 clinical practice review in the New England Journal of Medicine offers a comprehensive update on how to diagnose and manage polymyalg...
Read More — NEJM Clinical Practice Review: Polymyalgia Rheumatica Diagnosis and Management in Adults Over 50 »A landmark phase 3 trial found that obinutuzumab, a targeted anti-CD20 antibody, significantly outperformed placebo in reducing disease acti...
Read More — Obinutuzumab Achieves Superior Disease Control in Phase 3 ALLEGORY Trial for Systemic Lupus Erythematosus »Researchers have identified overlapping biological pathways between IgA nephropathy and celiac disease, two autoimmune conditions that frequ...
Read More — Shared Molecular Mechanisms and Diagnostic Markers Identified in IgA Nephropathy and Celiac Disease »Scientists have identified a common gut fungus called Engyodontium that appears to worsen Crohn's disease by crowding out beneficial bacteri...
Read More — Gut Fungus Engyodontium Disrupts Protective Bacteria and Worsens Inflammation in Crohn's Disease »A 2026 PRISMA-based systematic review in the Journal of Dermatological Treatment examined every approved and guideline-recommended treatment...
Read More — Ruxolitinib Cream and Standard Therapies for Vitiligo: A 2026 Systematic Review of Approved and Guideline-Recommended Treatments »Phase 3 results announced in February 2026 show that obinutuzumab, an anti-CD20 monoclonal antibody, achieved significantly higher rates of...
Read More — Phase 3 MAJESTY Trial Shows Obinutuzumab Achieves Superior Complete Remission Over Tacrolimus in Primary Membranous Nephropathy »A pivotal clinical trial published in Nature Medicine in January 2026 found that an implantable vagus nerve stimulation device significantly...
Read More — Implantable Vagus Nerve Stimulator Reduces Rheumatoid Arthritis Activity in Pivotal RESET-RA Trial, Published in Nature Medicine »A 2026 retrospective study found that efgartigimod, a neonatal Fc receptor (FcRn) inhibitor, achieved recovery outcomes in Guillain-Barre sy...
Read More — Efgartigimod Shows Comparable Efficacy to IVIG in Guillain-Barre Syndrome with Faster Neurological Recovery »